Developer docs
API playgroundTry for free, no card

Search company profiles

Clinect

Full company profile

uuid0045eyt

Namestring
Clinect
Legal namestring
Clinect
Websiteurl
clinect.com.au
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Clinect is an Australian-based pharmaceutical company that supplies branded medicines and medical devices to hospital and pharmacy channels across Australia and New Zealand, operating as a wholly-owned subsidiary of EBOS Group Ltd. The company's product portfolio spans multiple therapeutic areas including cardiovascular, central nervous system, anti-inflammatory, antiviral, and oncology, with branded products such as Famvir (famciclovir), Naprosyn (naproxen), Haldol Decanoate (haloperidol), Valium (diazepam), Reagila (cariprazine), Largactil (chlorpromazine), and Kytril (granisetron). Clinect also distributes medical devices including the Neria Steel and Neria Soft subcutaneous infusion systems. Headquartered in Melbourne Docklands, the company focuses on clinically essential and niche products that require special regulatory attention and knowledge.

Beyond product distribution, Clinect provides a full suite of market-access services to international pharmaceutical companies seeking entry into the Australian and New Zealand markets. These services include regulatory affairs (TGA and Medsafe submissions covering PI, CMI, and labelling), reimbursement strategy and submissions (PBAC and PHARMAC), medical affairs including pharmacovigilance and drug information, validated cold-chain warehousing and distribution, key opinion leader engagement with Directors of Pharmacy in public hospitals and private healthcare organizations, and tailored sales and marketing solutions. The business model combines product acquisition and strategic partnering to bring niche treatments to market, with revenue generated through pharmaceutical product sales under PBS and PHARMAC regulated pricing. The company employs a sales-led go-to-market motion with direct enterprise sales targeting hospitals and pharmacies through established KOL relationships, with only two senior leaders publicly identified (Merryn Wallace, General Manager; Marcos Bernardo, Commercial Manager), indicating a lean operational structure consistent with a focused specialty distributor.

Short descriptiontext

Clinect is an Australian pharmaceutical subsidiary of EBOS Group that supplies branded niche medicines, clinically essential treatments, and medical devices to hospitals and pharmacies across Australia and New Zealand, with full-service market access capabilities covering regulatory, reimbursement, distribution, and KOL engagement.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMelbourne (Docklands), Australia
HQ citystring
Melbourne (Docklands)
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, pharmaceutical distribution, regulatory affairs services, cold chain logistics, medical device supply
Industry1 code
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Specialty Pharmaceutical Distribution
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Revenue generated from supplying pharmaceutical products and medical devices in Australia and New Zealand markets through strategic partnering and product acquisition.

clinect.com.au
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clinect is an Australian-based pharmaceutical company that supplies a portfolio of branded medicines and medical devices in Australia and New Zealand markets through strategic partnering and product acquisition. The company focuses on clinically essential and niche pharmaceutical products distributed to public hospitals, private healthcare organisations, and community and hospital pharmacies, with supporting services including regulatory affairs (TGA/Medsafe), reimbursement support (PBAC/PHARMAC), validated cold chain warehousing and distribution, medical affairs (pharmacovigilance, drug information), market entry strategy, and tailored sales and marketing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Clinect is an Australian-based pharmaceutical company that supplies a portfolio of medicines and medical devices in Australia and New Zealand. The company operates as a pharmaceutical products and services business, offering a comprehensive portfolio of branded medications across multiple therapeutic areas including cardiovascular, central nervous system, anti-inflammatory, antiviral, and oncology treatments. Products include Anaprox®, Bondronat®, Catapres®, Crysanal®, Famvir®, Haldol® Decanoate, Kytril®, Largactil®, Naprosyn®, Reagila®, Reminyl®, Tenormin®, Toradol®, Valium®, and ZYAMIS® among many others. In addition to pharmaceutical products, Clinect provides supporting services including market entry strategy, medical affairs, warehousing and distribution with cold chain capabilities, regulatory affairs (TGA and Medsafe submissions), key opinion leader relationships, reimbursement support (PBAC and PHARMAC), and sales and marketing services. The company focuses on specialty and niche pharmaceutical products that require special attention and regulatory expertise, distributing through hospital and pharmacy channels via strategic partnering and product acquisition.

Product and service61 records
1Market Entry Services
CategoryService
2Medical Affairs Services
CategoryService
3Warehousing & Distribution Services
CategoryService
4Regulatory Affairs Services
CategoryService
5Key Opinion Leader Relationship Services
CategoryService
6Reimbursement Services
CategoryService
7Sales & Marketing Services
CategoryService
8Neria Steel
CategoryMedical Device
9Neria Soft
CategoryMedical Device
10Anaprox
CategoryMedicine
Description

Anti-inflammatory pain relief medication containing Naproxen Sodium 550mg, supplied as 50 tablets in blister packaging for hospital and pharmacy channels in Australia and New Zealand.

11Bondronat
CategoryMedicine
Description

Bisphosphonate medication containing Ibandronate Sodium 50mg, supplied as 28 tablets in blister packaging for the treatment of bone conditions.

12Catapres
CategoryMedicine
Description

Antihypertensive medication containing Clonidine Hydrochloride, available in injectable (150mcg/mL, 5 ampoules) and tablet (100mcg, 150mcg, 100 tablets) formulations.

13Crysanal
CategoryMedicine
Description

Anti-inflammatory pain relief medication containing Naproxen Sodium 550mg, supplied as 50 tablets in blister packaging.

14Diltiazem CD
CategoryMedicine
Description

Calcium channel blocker containing Diltiazem Hydrochloride 120mg, supplied as 500 capsules in bottle packaging.

15Doxazosin
CategoryMedicine
Description

Alpha-blocker medication containing Doxazosin mesilate available in 2mg and 4mg tablet formulations, supplied as 500 tablets in bottles.

16Elovax
CategoryMedicine
Description

Antiviral medication containing Famciclovir 500mg for viral infections, supplied as 3 tablets in blister packaging.

17Famvir
CategoryMedicine
Description

Antiviral medication containing Famciclovir available in multiple strengths (125mg, 250mg, 500mg) and pack sizes (20-56 tablets) for herpes and shingles treatment.

18Felodur ER
CategoryMedicine
Description

Extended-release calcium channel blocker containing Felodipine available in 2.5mg, 5mg, and 10mg strengths, supplied as 30 tablets in blister packaging.

19Frisium
CategoryMedicine
Description

Benzodiazepine medication containing Clobazam 10mg, supplied as 50 tablets in blister packaging for anxiety and seizure disorders.

20Haldol Decanoate
CategoryMedicine
Description

Antipsychotic long-acting injection containing Haloperidol available in 50mg/1mL, 100mg/1mL, and 150mg/3mL formulations, supplied as 5 ampoules.

21Imdur
CategoryMedicine
Description

Antianginal medication containing Isosorbide Mononitrate available in 60mg and 120mg strengths, supplied as 30 tablets in blister packaging.

22Inderal
CategoryMedicine
Description

Beta-blocker medication containing Propranolol available in 10mg and 40mg strengths, supplied as 100 tablets in blister packaging.

23Iopidine
CategoryMedicine
Description

Ophthalmic solution containing Apraclonidine 5mg/mL, supplied as 5mL bottle for glaucoma treatment.

24Kytril
CategoryMedicine
Description

Antiemetic medication containing Granisetron available in injectable (1mg/1mL, 3mg/3mL) and tablet (2mg) formulations for chemotherapy-induced nausea.

25Largactil
CategoryMedicine
Description

Antipsychotic medication containing Chlorpromazine Hydrochloride available in injectable (50mg/2mL), oral suspension (25mg/5mL), and tablet (25mg, 100mg) formulations.

26Leustatin
CategoryMedicine
Description

Antimetabolite chemotherapy agent containing Cladribine 1mg/1mL, supplied as 1 vial for hairy cell leukemia treatment.

27Maraviroc Waymade
CategoryMedicine
Description

Antiretroviral medication containing Maraviroc available in 150mg and 300mg strengths, supplied as 60 tablets in blister packaging.

28Metaraminol Torbay
CategoryMedicine
Description

Vasopressor medication containing Metaraminol available in 5mg/10mL and 10mg/1mL injectable formulations, supplied as 10 ampoules.

29Monodur
CategoryMedicine
Description

Antianginal medication containing Isosorbide Mononitrate 120mg, supplied as 30 tablets in blister packaging.

30Naprosyn SR
CategoryMedicine
Description

Extended-release anti-inflammatory medication containing Naproxen available in 1g and 750mg strengths, supplied as 28 tablets in blister packaging.

31Naprosyn
CategoryMedicine
Description

Anti-inflammatory pain relief medication containing Naproxen 250mg, supplied as 50 tablets in blister packaging.

32Nozinan
CategoryMedicine
Description

Antipsychotic medication containing Levomepromazine Hydrochloride available in 25mg and 100mg tablet formulations, supplied as 100 tablets in blister packaging.

33Neulactil
CategoryMedicine
Description

Antipsychotic medication containing Periciazine available in 2.5mg and 10mg strengths, supplied as 100 tablets in blister packaging.

34Neupedix
CategoryMedicine
Description

Prostaglandin medication containing Alprostadil 500mcg/1mL, supplied as 5 ampoules for erectile dysfunction treatment.

35Persantin
CategoryMedicine
Description

Antiplatelet medication containing Dipyridamole 10mg/2mL, supplied as 5 ampoules for cardiovascular protection.

36Plendil ER
CategoryMedicine
Description

Extended-release calcium channel blocker containing Felodipine available in 2.5mg, 5mg, and 10mg strengths, supplied as 30 tablets in blister packaging.

37Pravastatin
CategoryMedicine
Description

Statin medication containing Pravastatin Sodium available in 20mg and 40mg strengths, supplied as 100 tablets in bottle packaging.

38Prednisone
CategoryMedicine
Description

Corticosteroid medication available in 1mg, 2.5mg, 5mg, and 20mg tablet formulations, supplied as 500 tablets in bottle packaging.

39Priadel
CategoryMedicine
Description

Mood stabilizer containing Lithium Carbonate 400mg, supplied as 100 tablets in blister packaging for bipolar disorder treatment.

40Primidone
CategoryMedicine
Description

Anticonvulsant medication containing Primidone 250mg, supplied as 100 tablets in bottle packaging.

41Proveblue
CategoryMedicine
Description

Diagnostic agent containing Methylene Blue 50mg/10mL, supplied as 5 ampoules for methemoglobinemia treatment.

42Proxen SR
CategoryMedicine
Description

Extended-release anti-inflammatory medication containing Naproxen available in 1g and 750mg strengths, supplied as 28 tablets in blister packaging.

43Reagila
CategoryMedicine
Description

Atypical antipsychotic containing Cariprazine available in 1.5mg, 3mg, 4.5mg, and 6mg capsule strengths, supplied as 30 capsules in blister packaging.

44Reminyl
CategoryMedicine
Description

Cholinesterase inhibitor containing Galantamine available in 8mg, 16mg, and 24mg capsule strengths, supplied as 28 capsules in blister packaging.

45Rocaltrol
CategoryMedicine
Description

Vitamin D analog containing Calcitriol 0.25mcg, supplied as 100 capsules in blister packaging.

46Stemetil
CategoryMedicine
Description

Antiemetic medication containing Prochlorperazine mesilate 12.5mg/1mL, supplied as 10 ampoules.

47Synacthen
CategoryMedicine
Description

Adrenocorticotropic hormone (ACTH) containing Tetracosactide 0.25mg, supplied as 1 ampoule for adrenal function testing.

48Syntometrine
CategoryMedicine
Description

Uterotonic medication containing Oxytocin/Ergometrine maleate 5 IU/mL/0.5mg/mL, supplied as 5 ampoules for postpartum hemorrhage.

49Tenormin
CategoryMedicine
Description

Beta-blocker medication containing Atenolol 50mg, supplied as 30 tablets in blister packaging.

50Testavan
CategoryMedicine
Description

Testosterone replacement therapy gel containing Testosterone 20mg/1g, supplied as 56 doses/85.5g pump dispenser.

51Toradol
CategoryMedicine
Description

NSAID pain medication containing Ketorolac Trometamol available in injectable (10mg/mL, 30mg/1mL) and tablet (10mg) formulations.

52Tranexamic Acid Waymade
CategoryMedicine
Description

Antifibrinolytic medication containing Tranexamic Acid 500mg, supplied as 100 tablets in blister packaging.

53Trental
CategoryMedicine
Description

Vasodilator medication containing Pentoxifylline 400mg, supplied as 50 tablets in blister packaging.

54Trientine Waymade
CategoryMedicine
Description

Chelating agent containing Trientine dihydrochloride 250mg, supplied as 100 capsules in bottle packaging for Wilson's disease.

55Valium
CategoryMedicine
Description

Benzodiazepine medication containing Diazepam 5mg, supplied as 50 tablets in blister packaging.

56Verdye
CategoryMedicine
Description

Diagnostic imaging agent containing Indocyanine Green 25mg, supplied as 5 vials for liver function and ophthalmic imaging.

57Xadago
CategoryMedicine
Description

MAO-B inhibitor containing Safinamide available in 50mg and 100mg tablet strengths, supplied as 30 tablets in blister packaging for Parkinson's disease.

58Xorox
CategoryMedicine
Description

Topical antiviral cream containing Aciclovir 30mg/g, supplied as 4.5g tube for herpes treatment.

59Zarontin
CategoryMedicine
Description

Anticonvulsant medication containing Ethosuximide available in 250mg capsules and 250mg/5mL oral solution, supplied in bottles.

60Zestril
CategoryMedicine
Description

ACE inhibitor containing Lisinopril available in 5mg, 10mg, and 20mg tablet strengths, supplied as 30 tablets in blister packaging.

61ZYAMIS
CategoryMedicine
Description

Benzodiazepine pre-filled syringe containing Midazolam available in 2.5mg/0.25mL, 5mg/0.5mL, 7.5mg/0.75mL, and 10mg/1mL formulations for sedation.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty pharmaceutical company focused on prescription and OTC medicines across ANZ and Asia-Pacific. Comparable to Clinect in therapeutic-area breadth, channel coverage, and partnership-based product sourcing.

TypeDirect peer
Description

One of Australia's largest pharmaceutical wholesalers and distributors, serving community pharmacies with a broad portfolio including specialty products. Directly comparable as an ANZ pharma distributor with hospital and pharmacy channel coverage.

TypeBroad incumbent
Description

Australian subsidiary of global specialty pharma group Servier. Operates in overlapping therapeutic areas (cardiovascular, oncology, CNS) and follows a similar in-licensing / partnered commercialisation model in ANZ.

TypeDirect peer
Description

Australia's largest generic pharmaceutical company with branded specialty, OTC, and hospital portfolios. Competes with Clinect in hospital and pharmacy channels across overlapping therapeutic areas.

TypeDirect peer
Description

Australian specialty pharma company that partners with international firms to bring niche and oncology products to the ANZ market. Closest comparable to Clinect's "niche/specialty" in-licensing and distribution model.

TypeBroad incumbent
Description

Australian subsidiary of Aspen Pharmacare, distributing branded specialty and generic pharmaceuticals. Comparable channel footprint and product categories to Clinect, with broader international scale.

TypeEmerging player
Description

CSL subsidiary focused on specialty vaccines and biologics in ANZ and globally. Comparable to Clinect in cold chain capability, specialty product focus, and ANZ hospital channel.

TypeEmerging player
Description

ANZ specialty pharma company that in-licenses and distributes niche prescription products to hospitals and specialists. Closely comparable to Clinect's partnership-driven, niche-focus distribution model.

TypeDirect peer
Description

Major Australian pharmaceutical distributor and pharmacy services group (now part of Wesfarmers). Operates the same hospital and community pharmacy distribution channels that Clinect serves, with overlapping product portfolios.

TypeBroad incumbent
Description

Subsidiary of global generic manufacturer Apotex, with significant ANZ presence in prescription and specialty generics. Competes with Clinect's portfolio of mature molecules across hospital and pharmacy channels.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clinect

Specialty Pharmaceutical Distributionclinect.com.au

Clinect is an Australian pharmaceutical subsidiary of EBOS Group that supplies branded niche medicines, clinically essential treatments, and medical devices to hospitals and pharmacies across Australia and New Zealand, with full-service market access capabilities covering regulatory, reimbursement, distribution, and KOL engagement.

What Clinect does

Clinect is an Australian-based pharmaceutical company that supplies branded medicines and medical devices to hospital and pharmacy channels across Australia and New Zealand, operating as a wholly-owned subsidiary of EBOS Group Ltd. The company's product portfolio spans multiple therapeutic areas including cardiovascular, central nervous system, anti-inflammatory, antiviral, and oncology, with branded products such as Famvir (famciclovir), Naprosyn (naproxen), Haldol Decanoate (haloperidol), Valium (diazepam), Reagila (cariprazine), Largactil (chlorpromazine), and Kytril (granisetron). Clinect also distributes medical devices including the Neria Steel and Neria Soft subcutaneous infusion systems. Headquartered in Melbourne Docklands, the company focuses on clinically essential and niche products that require special regulatory attention and knowledge.

Beyond product distribution, Clinect provides a full suite of market-access services to international pharmaceutical companies seeking entry into the Australian and New Zealand markets. These services include regulatory affairs (TGA and Medsafe submissions covering PI, CMI, and labelling), reimbursement strategy and submissions (PBAC and PHARMAC), medical affairs including pharmacovigilance and drug information, validated cold-chain warehousing and distribution, key opinion leader engagement with Directors of Pharmacy in public hospitals and private healthcare organizations, and tailored sales and marketing solutions. The business model combines product acquisition and strategic partnering to bring niche treatments to market, with revenue generated through pharmaceutical product sales under PBS and PHARMAC regulated pricing. The company employs a sales-led go-to-market motion with direct enterprise sales targeting hospitals and pharmacies through established KOL relationships, with only two senior leaders publicly identified (Merryn Wallace, General Manager; Marcos Bernardo, Commercial Manager), indicating a lean operational structure consistent with a focused specialty distributor.

Clinect firmographics

Firmographics
Name
Clinect
Legal name
Clinect
Website
https://clinect.com.au
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Clinect is an Australian pharmaceutical subsidiary of EBOS Group that supplies branded niche medicines, clinically essential treatments, and medical devices to hospitals and pharmacies across Australia and New Zealand, with full-service market access capabilities covering regulatory, reimbursement, distribution, and KOL engagement.
Ownership category
akta.pro rank

Where Clinect is headquartered

Location

Headquarters

HQ city
Melbourne (Docklands)
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Clinect business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Revenue generated from supplying pharmaceutical products and medical devices in Australia and New Zealand markets through strategic partnering and product acquisition.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Clinect product offering

Product offering

Core offering

Clinect is an Australian-based pharmaceutical company that supplies a portfolio of branded medicines and medical devices in Australia and New Zealand markets through strategic partnering and product acquisition. The company focuses on clinically essential and niche pharmaceutical products distributed to public hospitals, private healthcare organisations, and community and hospital pharmacies, with supporting services including regulatory affairs (TGA/Medsafe), reimbursement support (PBAC/PHARMAC), validated cold chain warehousing and distribution, medical affairs (pharmacovigilance, drug information), market entry strategy, and tailored sales and marketing.

Product overview

Clinect is an Australian-based pharmaceutical company that supplies a portfolio of medicines and medical devices in Australia and New Zealand. The company operates as a pharmaceutical products and services business, offering a comprehensive portfolio of branded medications across multiple therapeutic areas including cardiovascular, central nervous system, anti-inflammatory, antiviral, and oncology treatments. Products include Anaprox®, Bondronat®, Catapres®, Crysanal®, Famvir®, Haldol® Decanoate, Kytril®, Largactil®, Naprosyn®, Reagila®, Reminyl®, Tenormin®, Toradol®, Valium®, and ZYAMIS® among many others. In addition to pharmaceutical products, Clinect provides supporting services including market entry strategy, medical affairs, warehousing and distribution with cold chain capabilities, regulatory affairs (TGA and Medsafe submissions), key opinion leader relationships, reimbursement support (PBAC and PHARMAC), and sales and marketing services. The company focuses on specialty and niche pharmaceutical products that require special attention and regulatory expertise, distributing through hospital and pharmacy channels via strategic partnering and product acquisition.

Differentiator

Problem solved

Functional benefit

Products and services

  • Market Entry Services
  • Medical Affairs Services
  • Warehousing & Distribution Services
  • Regulatory Affairs Services
  • Key Opinion Leader Relationship Services
  • Reimbursement Services
  • Sales & Marketing Services
  • Neria Steel
  • Neria Soft
  • Anaprox Anti-inflammatory pain relief medication containing Naproxen Sodium 550mg, supplied as 50 tablets in blister packaging for hospital and pharmacy channels in Australia and New Zealand.
  • Bondronat Bisphosphonate medication containing Ibandronate Sodium 50mg, supplied as 28 tablets in blister packaging for the treatment of bone conditions.
  • Catapres Antihypertensive medication containing Clonidine Hydrochloride, available in injectable (150mcg/mL, 5 ampoules) and tablet (100mcg, 150mcg, 100 tablets) formulations.
  • Crysanal Anti-inflammatory pain relief medication containing Naproxen Sodium 550mg, supplied as 50 tablets in blister packaging.
  • Diltiazem CD Calcium channel blocker containing Diltiazem Hydrochloride 120mg, supplied as 500 capsules in bottle packaging.
  • Doxazosin Alpha-blocker medication containing Doxazosin mesilate available in 2mg and 4mg tablet formulations, supplied as 500 tablets in bottles.
  • Elovax Antiviral medication containing Famciclovir 500mg for viral infections, supplied as 3 tablets in blister packaging.
  • Famvir Antiviral medication containing Famciclovir available in multiple strengths (125mg, 250mg, 500mg) and pack sizes (20-56 tablets) for herpes and shingles treatment.
  • Felodur ER Extended-release calcium channel blocker containing Felodipine available in 2.5mg, 5mg, and 10mg strengths, supplied as 30 tablets in blister packaging.
  • Frisium Benzodiazepine medication containing Clobazam 10mg, supplied as 50 tablets in blister packaging for anxiety and seizure disorders.
  • Haldol Decanoate Antipsychotic long-acting injection containing Haloperidol available in 50mg/1mL, 100mg/1mL, and 150mg/3mL formulations, supplied as 5 ampoules.
  • Imdur Antianginal medication containing Isosorbide Mononitrate available in 60mg and 120mg strengths, supplied as 30 tablets in blister packaging.
  • Inderal Beta-blocker medication containing Propranolol available in 10mg and 40mg strengths, supplied as 100 tablets in blister packaging.
  • Iopidine Ophthalmic solution containing Apraclonidine 5mg/mL, supplied as 5mL bottle for glaucoma treatment.
  • Kytril Antiemetic medication containing Granisetron available in injectable (1mg/1mL, 3mg/3mL) and tablet (2mg) formulations for chemotherapy-induced nausea.
  • Largactil Antipsychotic medication containing Chlorpromazine Hydrochloride available in injectable (50mg/2mL), oral suspension (25mg/5mL), and tablet (25mg, 100mg) formulations.
  • Leustatin Antimetabolite chemotherapy agent containing Cladribine 1mg/1mL, supplied as 1 vial for hairy cell leukemia treatment.
  • Maraviroc Waymade Antiretroviral medication containing Maraviroc available in 150mg and 300mg strengths, supplied as 60 tablets in blister packaging.
  • Metaraminol Torbay Vasopressor medication containing Metaraminol available in 5mg/10mL and 10mg/1mL injectable formulations, supplied as 10 ampoules.
  • Monodur Antianginal medication containing Isosorbide Mononitrate 120mg, supplied as 30 tablets in blister packaging.
  • Naprosyn SR Extended-release anti-inflammatory medication containing Naproxen available in 1g and 750mg strengths, supplied as 28 tablets in blister packaging.
  • Naprosyn Anti-inflammatory pain relief medication containing Naproxen 250mg, supplied as 50 tablets in blister packaging.
  • Nozinan Antipsychotic medication containing Levomepromazine Hydrochloride available in 25mg and 100mg tablet formulations, supplied as 100 tablets in blister packaging.
  • Neulactil Antipsychotic medication containing Periciazine available in 2.5mg and 10mg strengths, supplied as 100 tablets in blister packaging.
  • Neupedix Prostaglandin medication containing Alprostadil 500mcg/1mL, supplied as 5 ampoules for erectile dysfunction treatment.
  • Persantin Antiplatelet medication containing Dipyridamole 10mg/2mL, supplied as 5 ampoules for cardiovascular protection.
  • Plendil ER Extended-release calcium channel blocker containing Felodipine available in 2.5mg, 5mg, and 10mg strengths, supplied as 30 tablets in blister packaging.
  • Pravastatin Statin medication containing Pravastatin Sodium available in 20mg and 40mg strengths, supplied as 100 tablets in bottle packaging.
  • Prednisone Corticosteroid medication available in 1mg, 2.5mg, 5mg, and 20mg tablet formulations, supplied as 500 tablets in bottle packaging.
  • Priadel Mood stabilizer containing Lithium Carbonate 400mg, supplied as 100 tablets in blister packaging for bipolar disorder treatment.
  • Primidone Anticonvulsant medication containing Primidone 250mg, supplied as 100 tablets in bottle packaging.
  • Proveblue Diagnostic agent containing Methylene Blue 50mg/10mL, supplied as 5 ampoules for methemoglobinemia treatment.
  • Proxen SR Extended-release anti-inflammatory medication containing Naproxen available in 1g and 750mg strengths, supplied as 28 tablets in blister packaging.
  • Reagila Atypical antipsychotic containing Cariprazine available in 1.5mg, 3mg, 4.5mg, and 6mg capsule strengths, supplied as 30 capsules in blister packaging.
  • Reminyl Cholinesterase inhibitor containing Galantamine available in 8mg, 16mg, and 24mg capsule strengths, supplied as 28 capsules in blister packaging.
  • Rocaltrol Vitamin D analog containing Calcitriol 0.25mcg, supplied as 100 capsules in blister packaging.
  • Stemetil Antiemetic medication containing Prochlorperazine mesilate 12.5mg/1mL, supplied as 10 ampoules.
  • Synacthen Adrenocorticotropic hormone (ACTH) containing Tetracosactide 0.25mg, supplied as 1 ampoule for adrenal function testing.
  • Syntometrine Uterotonic medication containing Oxytocin/Ergometrine maleate 5 IU/mL/0.5mg/mL, supplied as 5 ampoules for postpartum hemorrhage.
  • Tenormin Beta-blocker medication containing Atenolol 50mg, supplied as 30 tablets in blister packaging.
  • Testavan Testosterone replacement therapy gel containing Testosterone 20mg/1g, supplied as 56 doses/85.5g pump dispenser.
  • Toradol NSAID pain medication containing Ketorolac Trometamol available in injectable (10mg/mL, 30mg/1mL) and tablet (10mg) formulations.
  • Tranexamic Acid Waymade Antifibrinolytic medication containing Tranexamic Acid 500mg, supplied as 100 tablets in blister packaging.
  • Trental Vasodilator medication containing Pentoxifylline 400mg, supplied as 50 tablets in blister packaging.
  • Trientine Waymade Chelating agent containing Trientine dihydrochloride 250mg, supplied as 100 capsules in bottle packaging for Wilson's disease.
  • Valium Benzodiazepine medication containing Diazepam 5mg, supplied as 50 tablets in blister packaging.
  • Verdye Diagnostic imaging agent containing Indocyanine Green 25mg, supplied as 5 vials for liver function and ophthalmic imaging.
  • Xadago MAO-B inhibitor containing Safinamide available in 50mg and 100mg tablet strengths, supplied as 30 tablets in blister packaging for Parkinson's disease.
  • Xorox Topical antiviral cream containing Aciclovir 30mg/g, supplied as 4.5g tube for herpes treatment.
  • Zarontin Anticonvulsant medication containing Ethosuximide available in 250mg capsules and 250mg/5mL oral solution, supplied in bottles.
  • Zestril ACE inhibitor containing Lisinopril available in 5mg, 10mg, and 20mg tablet strengths, supplied as 30 tablets in blister packaging.
  • ZYAMIS Benzodiazepine pre-filled syringe containing Midazolam available in 2.5mg/0.25mL, 5mg/0.5mL, 7.5mg/0.75mL, and 10mg/1mL formulations for sedation.

Companies that use Clinect

Customer profile

Segments3 records

Ideal customer profiles3 records

Clinect technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Clinect partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Clinect competitors and assessment

Company assessment

Direct peers

  • iNova Pharmaceuticals: Specialty pharmaceutical company focused on prescription and OTC medicines across ANZ and Asia-Pacific. Comparable to Clinect in therapeutic-area breadth, channel coverage, and partnership-based product sourcing.
  • Sigma Healthcare: One of Australia's largest pharmaceutical wholesalers and distributors, serving community pharmacies with a broad portfolio including specialty products. Directly comparable as an ANZ pharma distributor with hospital and pharmacy channel coverage.
  • Arrotex Pharmaceuticals: Australia's largest generic pharmaceutical company with branded specialty, OTC, and hospital portfolios. Competes with Clinect in hospital and pharmacy channels across overlapping therapeutic areas.
  • Specialised Therapeutics Australia: Australian specialty pharma company that partners with international firms to bring niche and oncology products to the ANZ market. Closest comparable to Clinect's "niche/specialty" in-licensing and distribution model.
  • Australian Pharmaceutical Industries (API): Major Australian pharmaceutical distributor and pharmacy services group (now part of Wesfarmers). Operates the same hospital and community pharmacy distribution channels that Clinect serves, with overlapping product portfolios.

Broad incumbents

  • Servier Australia: Australian subsidiary of global specialty pharma group Servier. Operates in overlapping therapeutic areas (cardiovascular, oncology, CNS) and follows a similar in-licensing / partnered commercialisation model in ANZ.
  • Aspen Pharmacare Australia: Australian subsidiary of Aspen Pharmacare, distributing branded specialty and generic pharmaceuticals. Comparable channel footprint and product categories to Clinect, with broader international scale.
  • Apotex Australia & New Zealand: Subsidiary of global generic manufacturer Apotex, with significant ANZ presence in prescription and specialty generics. Competes with Clinect's portfolio of mature molecules across hospital and pharmacy channels.

Emerging players

  • Seqirus: CSL subsidiary focused on specialty vaccines and biologics in ANZ and globally. Comparable to Clinect in cold chain capability, specialty product focus, and ANZ hospital channel.
  • Link Healthcare: ANZ specialty pharma company that in-licenses and distributes niche prescription products to hospitals and specialists. Closely comparable to Clinect's partnership-driven, niche-focus distribution model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key highlights6 records

Customer concentration

Clinect social profiles

Digital presence

Clinect financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clinect leadership team

Management profile

Number of profiles

Profiles2 records

Clinect funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clinect M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinect

What does Clinect do?

Clinect is an Australian-based pharmaceutical company that supplies a portfolio of branded medicines and medical devices in Australia and New Zealand markets through strategic partnering and product acquisition. The company focuses on clinically essential and niche pharmaceutical products distributed to public hospitals, private healthcare organisations, and community and hospital pharmacies, with supporting services including regulatory affairs (TGA/Medsafe), reimbursement support (PBAC/PHARMAC), validated cold chain warehousing and distribution, medical affairs (pharmacovigilance, drug information), market entry strategy, and tailored sales and marketing.

Is Clinect a public or private company?

Clinect is a private company. It is classified as corporate owned and is currently operating.

When was Clinect founded?

Clinect was founded in -1. It employs 1 to 10 people.

Where is Clinect based?

Clinect is headquartered in Melbourne (Docklands), Australia, in the Oceania region.

How does Clinect make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Clinect's main competitors?

Direct peers on record are iNova Pharmaceuticals, Sigma Healthcare, Arrotex Pharmaceuticals, Specialised Therapeutics Australia and Australian Pharmaceutical Industries (API). Broad incumbents are Servier Australia, Aspen Pharmacare Australia and Apotex Australia & New Zealand. Emerging players are Seqirus and Link Healthcare.

Does Clinect have an API?

No public API is recorded for Clinect.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales